Porr Acquires VAMED, Medicare Ratings Revealed, Indian Cough Syrup Clarification
Published on: Oct. 12, 2025, 2:30 a.m. | Source: Devdiscourse
Porr acquires VAMED's Austrian assets while Strabag exits the deal. The U.S. releases 2026 Medicare ratings, impacting health insurer bonuses. CVS, UnitedHealth, Elevance, and Humana scores detailed. The FDA confirms toxic Indian cough syrups were not sent to the U.S., citing India's regulatory gaps.
